Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study

ConclusionsThere were considerable differences in risk of hospitalization or secondary healthcare visits due to hypoglycemic coma between basal insulin treatments in real‐life clinical practice. © 2013 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley & Sons, Ltd.

Source: Pharmacoepidemiology and Drug Safety - October 1, 2013 Category: Drugs & Pharmacology Authors: Jari Haukka, Fabian Hoti, Panu Erästö, Tero Saukkonen, Sari Mäkimattila, Pasi Korhonen Tags: Original Report Source Type: research